The Treatment of Carcinoma of the Prostate

This contribution to the discussion must take the form merely of an impersonal review of more recent progress in the treatment of prostatic cancer—developments which are mainly due to the work of Huggins and his collaborators at the University of Chicago (on treatment of carcinoma of the prostate by castration and by the administration of œstrogenic substances), to Herrold (treatment with œstrogens), and to Munger (auxiliary treatment by X-irradiation of the testes). I can lay no claim to any first-hand acquaintance with the clinical problem, and one's only justification for presenting this survey is that the new discoveries are of considerable fundamental as well as practical importance, and that they bear a close relation to problems which we have been investigating (at the Chester Beatty Research Institute of the Royal Cancer Hospital) along more general lines.